Eight-Week Clinical Research on Dzeny AI Therapist Demonstrates Clinically Significant Improvements Across Multiple Validated Mental Health Measures ...

Addresses a Significant Unmet Need in Japan as First and Only Approved Treatment Option for GADPITTSBURGH, March 23, 2026 /PRNewswire/ -- Viatris Inc.

Research finds that a single dose of LSD can alleviate the symptoms of anxiety in those who do not find relief from other current treatments ...

Imagine you're about to give a presentation to a room full of people.

Amelia seemingly had it all - a loving fiancé, a fulfilling job and a booming social life. So, when she began experiencing crippling anxiety and strange delusions, she truly felt like she was going ...

Detailed price information for Definium Therapeutics Inc (DFTX-Q) from The Globe and Mail including charting and trades.

In early March 2026, Helus Pharma, a Cybin subsidiary, reported positive topline Phase 2 results for HLP004 as an adjunctive intramuscular treatment for adults with moderate-to-severe generalized ...

Market News Updates News Commentary - Treatments for Generalized Anxiety Disorder (GAD) are getting better and more accessible, which is good news for millions of people dealing with constant worry ...

Detailed price information for Definium Therapeutics Inc (DFTX-Q) from The Globe and Mail including charting and trades.

Anxiety disorders don’t suddenly appear. You may experience early warning signs that feel like everyday habits or personality traits before you even consider visiting a therapist. “Subtler signs are ...

South Carolina resident Mary Lynn Ellison is suing Southwest Airlines for more than $75,000 over a February 2024 incident According to the complaint, Southwest failed to provide proper wheelchair ...

(RTTNews) - HELUS Pharma (HELP) reported its third-quarter fiscal 2026 financial results, noting continued operational execution and advancement across its clinical-stage neuroscience programs. The ...